Carlos Belmonte	Avizorex (P, C, I), Matrix Biology Institute, Cooper Vision (F)
Jason J. Nichols	Alcon, Allergan, Vistakon, (F); Alcon (R)
Stephanie M. Cox	Alcon, Allergan, BruderHealthcare, ElevenBiotherapeutics, Oculus, Kala, Shire, TearScience, Vistakon (F)
James A. Brock	None
Carolyn G. Begley	Coopervision, Santen Pharmaceutical (F); Johnson & Johnson Vision Care (C)
David A. Bereiter	None
Darlene A. Dartt	Allergan, Coopervision (C)
Anat Galor	Allergan, Shire (C), Veterans Affaies, NIH grants (F)
Pedram Hamrah	Coopervision (F), Eyegate Pharma, Jade Therapeutics, Novabay, Revision Optics, Santen, Valeant (C), Allergan, Bausch & Lomb, Dompe, GlaxoSmithKline, Shire (F, C).
Jason J. Ivanusic	None
Deborah Jacobs	BostonSight (E); TECLens (C)
Nancy A. McNamara	None
Mark I. Rosenblatt	Alcon, Roche, Santen (C), Laurel Therapeutics (F, C), Weill Cornell Medical College, University of Illinois at Chicago (P), Sarentis Therapeutics (F,I,C)
Fiona Stapleton	None
James S. Wolffsohn	Alcon, Aston EyeTech, Bausch & Lomb, BetterVision Ltd, CooperVision, Eaglet Eye, European Union, Eyebag, EMPharma, EyeDocs, Gelflex, Innovate UK, Johnson & Johnson Vision Care, Lenstec, Medmont, Rayner, Théa, Optimec, Visioncare Research (F); Aston EyeTech (I); British Contact Lens Association, University of Houston, Visioncare Research, CooperVision (C); Portable Aberrometer, Contrast Sensitivity Chart (P); Johnson & Johnson (R)

F (Financial Support), I (Personal Financial Interest), E (Employment), C (Consultant), P (Patent), R (Recipient), N (No Commercial Relationship), S (non-remunerative).